Factor assay in victims of snake bite: Experience from a tertiary care institute in South India

INTRODUCTION: Snake bites tend to cause a high mortality in those who develop coagulopathy. However, there is very limited literature on clotting factor assays in these patients, especially in the presence of clinical bleeding. The aim was to assess the coagulation profile and individual coagulation...

Full description

Bibliographic Details
Main Authors: Aboobacker Mohamed Rafi, Susheela Jacob Innah
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Asian Journal of Transfusion Science
Subjects:
Online Access:http://www.ajts.org/article.asp?issn=0973-6247;year=2022;volume=16;issue=2;spage=175;epage=179;aulast=Rafi
_version_ 1798006469181833216
author Aboobacker Mohamed Rafi
Susheela Jacob Innah
author_facet Aboobacker Mohamed Rafi
Susheela Jacob Innah
author_sort Aboobacker Mohamed Rafi
collection DOAJ
description INTRODUCTION: Snake bites tend to cause a high mortality in those who develop coagulopathy. However, there is very limited literature on clotting factor assays in these patients, especially in the presence of clinical bleeding. The aim was to assess the coagulation profile and individual coagulation factors in patients with hematotoxic snake bites. MATERIALS AND METHODS: This was a prospective observational study of clotting factor levels in victims of snake bites with hematotoxicity admitted to a single hospital in south India for 12 months. In 43 individuals who fulfilled the criteria, we measured platelet count, prothrombin time (PT), international normalized ratio, activated partial thromboplastin time (aPTT), fibrinogen levels, coagulation factors V, VII, VIII, IX, and X, and the qualitative factor XIII assay. RESULTS: Forty-three patients fulfilled the criteria and their samples were studied. There were 36 Russell's viper (Daboia russelli), 4 Hump-nosed pit viper (Hypnale hypnale), and 3 unknown snake bite victims samples, in which factor assays were done. All the Russell viper bite victims without a recordable clotting screen had deficiency of Factor V (0.5%–49.62%, Mean – 20.27%), Factor X (0.08%–92.3%, Mean – 70.73%), and qualitative factor XIII. Pit viper patients showed normal levels of Factor I, V, VII, VIII, IX, X, and XIII despite prolonged PT and aPTT. CONCLUSIONS: Early detection and treatment of envenomation remains the cornerstone of managing snake venom-induced consumptive coagulopathy. Anti-snake venom plays a major role in the reversal of coagulopathy. Blood and blood products would be useful when coagulopathy does not revert by ASV alone. Evidence-based transfusion can be implemented and cryoprecipitate may be used as many of the patients had factor XIII and fibrinogen deficiency as part of venom-induced coagulopathy. To improve patient management and thereby the outcome of patients CMEs and training programs for the treating physicians also has to be implemented so that guidelines are formulated and followed.
first_indexed 2024-04-11T12:56:16Z
format Article
id doaj.art-a8e31344da2c4983808de9ede8ef7f71
institution Directory Open Access Journal
issn 0973-6247
1998-3565
language English
last_indexed 2024-04-11T12:56:16Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Transfusion Science
spelling doaj.art-a8e31344da2c4983808de9ede8ef7f712022-12-22T04:23:04ZengWolters Kluwer Medknow PublicationsAsian Journal of Transfusion Science0973-62471998-35652022-01-0116217517910.4103/ajts.AJTS_104_18Factor assay in victims of snake bite: Experience from a tertiary care institute in South IndiaAboobacker Mohamed RafiSusheela Jacob InnahINTRODUCTION: Snake bites tend to cause a high mortality in those who develop coagulopathy. However, there is very limited literature on clotting factor assays in these patients, especially in the presence of clinical bleeding. The aim was to assess the coagulation profile and individual coagulation factors in patients with hematotoxic snake bites. MATERIALS AND METHODS: This was a prospective observational study of clotting factor levels in victims of snake bites with hematotoxicity admitted to a single hospital in south India for 12 months. In 43 individuals who fulfilled the criteria, we measured platelet count, prothrombin time (PT), international normalized ratio, activated partial thromboplastin time (aPTT), fibrinogen levels, coagulation factors V, VII, VIII, IX, and X, and the qualitative factor XIII assay. RESULTS: Forty-three patients fulfilled the criteria and their samples were studied. There were 36 Russell's viper (Daboia russelli), 4 Hump-nosed pit viper (Hypnale hypnale), and 3 unknown snake bite victims samples, in which factor assays were done. All the Russell viper bite victims without a recordable clotting screen had deficiency of Factor V (0.5%–49.62%, Mean – 20.27%), Factor X (0.08%–92.3%, Mean – 70.73%), and qualitative factor XIII. Pit viper patients showed normal levels of Factor I, V, VII, VIII, IX, X, and XIII despite prolonged PT and aPTT. CONCLUSIONS: Early detection and treatment of envenomation remains the cornerstone of managing snake venom-induced consumptive coagulopathy. Anti-snake venom plays a major role in the reversal of coagulopathy. Blood and blood products would be useful when coagulopathy does not revert by ASV alone. Evidence-based transfusion can be implemented and cryoprecipitate may be used as many of the patients had factor XIII and fibrinogen deficiency as part of venom-induced coagulopathy. To improve patient management and thereby the outcome of patients CMEs and training programs for the treating physicians also has to be implemented so that guidelines are formulated and followed.http://www.ajts.org/article.asp?issn=0973-6247;year=2022;volume=16;issue=2;spage=175;epage=179;aulast=Raficoagulationfactor assayssnake bitevenom-induced coagulopathy
spellingShingle Aboobacker Mohamed Rafi
Susheela Jacob Innah
Factor assay in victims of snake bite: Experience from a tertiary care institute in South India
Asian Journal of Transfusion Science
coagulation
factor assays
snake bite
venom-induced coagulopathy
title Factor assay in victims of snake bite: Experience from a tertiary care institute in South India
title_full Factor assay in victims of snake bite: Experience from a tertiary care institute in South India
title_fullStr Factor assay in victims of snake bite: Experience from a tertiary care institute in South India
title_full_unstemmed Factor assay in victims of snake bite: Experience from a tertiary care institute in South India
title_short Factor assay in victims of snake bite: Experience from a tertiary care institute in South India
title_sort factor assay in victims of snake bite experience from a tertiary care institute in south india
topic coagulation
factor assays
snake bite
venom-induced coagulopathy
url http://www.ajts.org/article.asp?issn=0973-6247;year=2022;volume=16;issue=2;spage=175;epage=179;aulast=Rafi
work_keys_str_mv AT aboobackermohamedrafi factorassayinvictimsofsnakebiteexperiencefromatertiarycareinstituteinsouthindia
AT susheelajacobinnah factorassayinvictimsofsnakebiteexperiencefromatertiarycareinstituteinsouthindia